Literature DB >> 9579663

Glutamate uptake is decreased tardively in the spinal cord of FALS mice.

T Canton1, J Pratt, J M Stutzmann, A Imperato, A Boireau.   

Abstract

This study examined high affinity Na+-dependent uptake of glutamate in synaptosomal preparations from spinal cord in mice that express a dominant mutation of human copper/zinc superoxide dismutase (SOD1) and represent an animal model of amyotrophic lateral sclerosis (ALS). Their muscle strength was also monitored by a grip traction test throughout their lifespan. The high affinity Na+-dependent uptake of [3H]glutamate was decreased between 120 and 150 days of age. A marked and significant decrease in Vmax (-40.2%; p < 0.001) on whole spinal cord synaptosomes was observed at 150 days, with no change in Km. This significant decrease was reached a week before the animals died (157.2 +/- 2.2 days) and corresponded to a considerable fall in muscle strength (25% loss between 120 and 140 days, p < 0.001). The FALS mouse model therefore reproduces the decrease in glutamate uptake reported in humans suffering from sporadic or familial ALS. These results are discussed in terms of a possible tardive involvement of glutamate uptake deficiency in human ALS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9579663     DOI: 10.1097/00001756-199803300-00001

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  15 in total

1.  Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration.

Authors:  Y H Gong; A S Parsadanian; A Andreeva; W D Snider; J L Elliott
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

2.  SOD1-G93A mice exhibit muscle-fiber-type-specific decreases in glucose uptake in the absence of whole-body changes in metabolism.

Authors:  Susan E Smittkamp; Jill K Morris; Gregory L Bomhoff; Mark E Chertoff; Paige C Geiger; John A Stanford
Journal:  Neurodegener Dis       Date:  2013-09-06       Impact factor: 2.977

3.  Measures of bulbar and spinal motor function, muscle innervation, and mitochondrial function in ALS rats.

Authors:  Susan E Smittkamp; Heather N Spalding; Jordan W Brown; Anisha A Gupte; Jie Chen; Hiroshi Nishimune; Paige C Geiger; John A Stanford
Journal:  Behav Brain Res       Date:  2010-03-06       Impact factor: 3.332

Review 4.  Astrogliosis in CNS pathologies: is there a role for microglia?

Authors:  Dan Zhang; Xiaoming Hu; Li Qian; James P O'Callaghan; Jau-Shyong Hong
Journal:  Mol Neurobiol       Date:  2010-02-12       Impact factor: 5.590

5.  Disease progression in a transgenic model of familial amyotrophic lateral sclerosis is dependent on both neuronal and non-neuronal zinc binding proteins.

Authors:  Krishna Puttaparthi; William L Gitomer; Uma Krishnan; Marjatta Son; Bhagya Rajendran; Jeffrey L Elliott
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

Review 6.  Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis.

Authors:  P J Shaw; C J Eggett
Journal:  J Neurol       Date:  2000-03       Impact factor: 4.849

Review 7.  Amyotrophic lateral sclerosis: progress and prospects for treatment.

Authors:  Michel Dib
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  Nordihydroguaiaretic acid increases glutamate uptake in vitro and in vivo: therapeutic implications for amyotrophic lateral sclerosis.

Authors:  William Boston-Howes; Eric O Williams; Alexey Bogush; Maura Scolere; Piera Pasinelli; Davide Trotti
Journal:  Exp Neurol       Date:  2008-06-24       Impact factor: 5.330

Review 9.  Main path and byways: non-vesicular glutamate release by system xc(-) as an important modifier of glutamatergic neurotransmission.

Authors:  Ann Massie; Séverine Boillée; Sandra Hewett; Lori Knackstedt; Jan Lewerenz
Journal:  J Neurochem       Date:  2015-09-29       Impact factor: 5.372

10.  Time-course and characterization of orolingual motor deficits in B6SJL-Tg(SOD1-G93A)1Gur/J mice.

Authors:  S E Smittkamp; J W Brown; J A Stanford
Journal:  Neuroscience       Date:  2007-10-30       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.